Medical News

RSS

Blood microRNA biomarker may have potential to detect head and neck cancer

Researchers at Flinders University are expanding work on a promising blood test model to help predict or diagnose head and neck cancer, a difficult cancer to pick up early and treat.

1 Sep 2020

Research project to understand the psychological aspects of COVID-19

SMU Office of Research and Tech Transfer - In response to the rapidly evolving COVID-19 pandemic, the Psychological Science Accelerator issued a call on March 13th for rapid and impactful proposals to understand the psychological and behavioural aspects of the pandemic.

1 Sep 2020

Cancer cells reshape, destroy or integrate into blood vessels to spread

In laboratory studies, Johns Hopkins Kimmel Cancer Center and Johns Hopkins University researchers observed a key step in how cancer cells may spread from a primary tumor to a distant site within the body, a process known as metastasis.

1 Sep 2020

'Natural killer' cells could be a powerful weapon to fight against lung cancer

Immune cells called 'natural killer' (NK) cells could be a powerful weapon for fighting lung cancer, according to Australian researchers.

1 Sep 2020

Growth hormone associated with early puberty and future breast cancer risk

When girls reach puberty at an unusually early age, they face a significantly higher risk of developing breast cancer later in life. Now, experts at Cincinnati Children's and the University of Cincinnati offer a new, unified explanation for why that increased risk occurs.

1 Sep 2020

Study offers hope for Norwegians suffering from chronic sleep disorders

Approximately 500 000 Norwegians suffer from chronic sleep disorders, also called insomnia. Researchers have long known that cognitive behavioural therapy for insomnia is the best documented treatment, but few people have access to such therapy.

1 Sep 2020

Common heart drugs are safe for patients hospitalized with COVID-19

Heart patients hospitalized with COVID-19 can safely continue taking angiotensin-converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARBs), according to the BRACE CORONA trial presented in a Hot Line session today at ESC Congress 2020.

1 Sep 2020

Survey shows pandemic will limit access to pediatric eye care

Pediatric ophthalmologists are a rarity in medicine. There are only about a thousand of them to serve America's 75 million children. And as other physicians fled private practice for hospitals or have been gobbled up by private equity firms, most pediatric ophthalmologists remain in private practice.

1 Sep 2020

Majority of Americans fear health-related bankruptcy, show surveys

As the COVID-19 pandemic continues to put lives and livelihoods at risk, 1 in 2 Americans say they fear a major health event could lead them to file for bankruptcy, marking a 5% increase since 2019.

1 Sep 2020

Researchers identify a new way to curb air pollution

Studies show those flashing real-time speed limit displays you see in neighborhoods are effective at telling motorists to slow down. Kerry Kelly thought: Could something like that help curb air pollution?

1 Sep 2020

Surgeons use patients' own stem cells to rebuild damaged corneas

Surgeons at Massachusetts Eye and Ear have replaced the ocular surface of four patients who each experienced chemical burns to one eye by using their own stem cells taken from the other healthy eye, in a technique known as "cultivated autologous limbal epithelial cell transplantation" (CALEC).

1 Sep 2020

Brain estrogen critical for astrocyte activation and neuroprotection

When the brain isn't getting enough oxygen, estrogen produced by neurons in both males and females hyperactivates another brain cell type called astrocytes to step up their usual support and protect brain function.

1 Sep 2020

Public health officials are our COVID commanders. Treat them with respect.

As a veteran who served back-to-back tours in Iraq, I initially cringed when commentators compared the COVID-19 crisis to wartime — no bullets, no blood and no one volunteered for this.

1 Sep 2020

Newly approved drugs in Canada lack key pediatric drug information

Newly approved drugs in Canada lack important pediatric drug information in their product monograph, according to an analysis led by McMaster University and McMaster Children's Hospital.

1 Sep 2020

Latest issue of Neurosurgical Focus journal examines anterior approaches to thoracolumbar spinal surgery

The September issue of Neurosurgical Focus looks at anterior approaches to thoracolumbar spinal surgery.

1 Sep 2020

Silicon nitride shows potent SARS-CoV-2 neutralization capability

A new study published on the preprint server bioRxiv* in August 2020 shows that the man-made compound silicon nitride, which is used in medical implants and high mechanical performance engineering applications, is capable of inactivating severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) at varying concentrations without causing cell cytotoxicity. This finding should be investigated to develop disinfectants to clear the virus from surfaces, preventing its spread.

1 Sep 2020

SAGE and Hindawi sign publishing partnership agreement

SAGE and Hindawi have recently entered into a publishing partnership agreement whereby the latter will publish and develop three SAGE gold open access journals for a period of at least three years.

1 Sep 2020

Human antibody response to SARS-CoV-2

A new study published on the preprint server medRxiv* in August 2020 reports on the human antibody response in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, which is key to developing vaccines and managing the pandemic, as well as designing and executing serologic testing and interpreting their results.

1 Sep 2020

Warnings can protect memory from misleading information

Warning witnesses about the threat of misinformation - before or after an event - significantly reduces the negative impact of misinformation on memory, according to new research performed at Tufts University.

1 Sep 2020

Low dose colchicine significantly reduces risk of cardiovascular death

An Australian-Dutch trial led by Perth GenesisCare cardiologists, Professor Peter Thompson and Dr Mark Nidorf, in collaboration with the Dutch Network for Cardiovascular Research (WCN) in the Netherlands, confirmed that low dose colchicine was safe, well-tolerated over the long-term, and significantly reduced the risk of cardiovascular death, heart attack, and ischemic stroke in patients with chronic coronary disease.

1 Sep 2020